Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 6, 1999, Pages 1925-1931

  Yanovski, Jack A ^a,e   Miller, Kirk D ^b   Kino, Tomoshige ^a   Friedman, Theodore C ^d   Chrousos, George P ^a   Tsigos, Constantine ^a,f   Falloon, Judith ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f Hellenic National Diabetes Center   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

17 HYDROXYCORTICOSTEROID; GLUCOSE; HYDROCORTISONE; INSULIN; PROTEINASE INHIBITOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; ENDOCRINE FUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCORTISONE BLOOD LEVEL; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPODYSTROPHY; MALE; METABOLIC REGULATION; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; OVIS;

EID: 0033304890     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.6.5740     Document Type: Article

References (38)

1. HIV-protease inhibitors
2. HIV-1 protease inhibitors: A review for clinicians
3. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
4. Therapeutic advances: Protease inhibitors for the treatment of HIV-1 infection
5. Drugs for HIV infection
6. Protease inhibitor-associated hyperglycemia
7. New-onset diabetes mellitus associated with use of protease inhibitor
8. Severe diabetes associated with protease inhibitor therapy
9. Marked hyperlipidaemia on ritonavir therapy
10. Hypertrophy of the breasts in a patient treated with indinavir
11. Abnormal fat distribution and use of protease inhibitors
12. Another case of breast hypertrophy in a patient treated with indinavir
13. Lipodystrophia with protease inhibitors in HIV patients
14. Lipodystrophy: Newly identified protease inhibitor side effect
15. Benign symmetric lipomatosis associated with protease inhibitors
16. A syndrome of peripheral lipodystrophy, hyperlipidemia, and insulin resistance in patients receiving HIV protease inhibitors
17. Visceral abdominal fat accumulation associated with use of indinavir
18. 'Buffalo hump' in men with HIV-infection
19. Blood pressure in relation to obesity, insulin and the hypothalamic-pituitary-adrenal axis in Swedish men
20. Stress-related cortisol secretion in men: Relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities
21. Body fat distribution, insulin resistance, and metabolic diseases
22. Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: A dose-response study
23. Pituitary-adrenocortical function in abdominal obesity of males: Evidence for decreased 21-hydroxylase activity
24. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution
25. Carney complex: The complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas
26. Diurnal rhythm of plasma delta sleep-inducing peptide in humans: Evidence for positive correlation with body temperature and negative correlation with rapid eye movement and slow wave sleep
27. Carbohydrate and lipid metabolism in endogenous hypercortisolism: Shared features with metabolic syndrome X and NIDDM
28. The metyrapone and dexamethasone suppression tests for the differential diagnosis of the adrenocorticotropin-dependent Cushing syndrome: A comparison
29. Differences in corticocotropin-releasing hormone-stimulated ACTH and cortisol before and after weight loss
30. Cushing's disease preceded by generalized glucocorticoid resistance: Clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation
31. Human corticosteroid binding globulin
32. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy
33. Phenobarbital-reduced increase in 6β-hydroxycortisol excretion: Clue to its significance in human urine
34. The adrenal cortex
35. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
36. Barraquer and Simons lipodystrophy. Complement anomalies and cutaneous leukocytoclasic vasculitis
37. Generalized lipodystrophy, congenital and acquired (lipoatrophy)